Redsense Medical AB (publ) (NGM: REDS)

Market Cap	122.68M
Revenue (ttm)	24.22M
Net Income (ttm)	-6.24M
Shares Out	16.44M
EPS (ttm)	-0.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,459
Average Volume	10,697
Open	6.70
Previous Close	6.80
Day's Range	6.50 - 6.72
52-Week Range	4.51 - 8.44
Beta	0.49
RSI	57.96
Earnings Date	Feb 21, 2025

About Redsense Medical AB

Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe, Canada, and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment; and Redsense venous sensor patch, a noninvasive patch that consists of an optic fiber and an absorbent sponge-like material. It also provides Redsense Clamp, an accessory to the alarm unit enabling automatic stop of the...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 5
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: REDS

Financial Performance

In 2023, Redsense Medical AB's revenue was 25.52 million, an increase of 52.32% compared to the previous year's 16.75 million. Losses were -4.51 million, -48.47% less than in 2022.